Alerus Financial’s Gilead Sciences GILD Stock Holding History

Alerus Financial’s Portfolio GILD Stock Details GILD Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q2	$1.14M	Buy	9,022 +691	+8%	+$91K	0.05%	171
2026 Q1	$1.16M	Buy	8,331 +8,302	+28,628%	+$1.16M	0.06%	136
2025 Q4	$3.56K	Hold	29	–	–	﹤0.01%	429
2025 Q3	$3.22K	Sell	29 -418	-94%	-$47.5K	﹤0.01%	463
2025 Q2	$49.6K	Buy	+447	New	+$47.6K	﹤0.01%	246
2020 Q2	–	Sell	-9,018	Closed	-$674K	–	162
2020 Q1	$674K	Buy	+9,018	New	+$623K	0.09%	115
2017 Q3	–	Sell	-4,640	Closed	-$328K	–	126
2017 Q2	$328K	Hold	4,640	–	–	0.05%	109
2017 Q1	$315K	Hold	4,640	–	–	0.05%	110
2016 Q4	$332K	Hold	4,640	–	–	0.05%	107
2016 Q3	$367K	Hold	4,640	–	–	0.06%	108
2016 Q2	$387K	Buy	+4,640	New	+$412K	0.06%	106

Other funds holding GILD

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM

Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return

State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return

Capital World Investors Los Angeles, California $846B AUM 46.74% 1-Year Est. Return

Invesco Atlanta, Georgia $1.26T AUM 61.52% 1-Year Est. Return

Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM

Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return

T. Rowe Price Associates Baltimore, Maryland $999B AUM 46.22% 1-Year Est. Return

Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return

Alerus Financial's GILD Position: Q2 2026 in Review

Alerus Financial increased its Gilead Sciences (GILD) stake by 8.3% in Q2 2026, buying an estimated $91K and bringing the position to 9,022 shares worth $1.14M. The position accounts for 0.05% of the portfolio, ranked #171.

Alerus Financial first reported a position in GILD in Q2 2016 and has held it in 11 quarters since. The position peaked at $1.16M in Q1 2026. 2,283 funds tracked by Wall St. Rank hold GILD as of Q2 2026.

Alerus Financial held 9,022 shares of Gilead Sciences worth $1.14M as of Q2 2026.
Alerus Financial bought 691 Gilead Sciences shares in Q2 2026, an estimated $91K.
Gilead Sciences made up 0.05% of Alerus Financial's portfolio in Q2 2026, its #171 holding.
Alerus Financial first reported a position in Gilead Sciences in Q2 2016 and has held it in 11 quarters since.
Alerus Financial's Gilead Sciences position peaked at $1.16M in Q1 2026.
2,283 funds tracked by Wall St. Rank held Gilead Sciences as of Q2 2026.

Based on Alerus Financial's 13F filing for Q2 2026, filed 14 Aug 2026.